Psoriasis Clinical Trials in East Windsor, New Jersey
7 recruitingEast Windsor, New Jersey
Showing 1–7 of 7 trials
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled43 locationsNCT06857942
Recruiting
Phase 4
Bimekizumab in Plaque Psoriasis
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai60 enrolled2 locationsNCT06336343
Recruiting
Phase 4
Duobrii in Combination With Biologics
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04119102
Recruiting
Phase 4
Taltz in Combination With Enstilar for Psoriasis
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04372277
Recruiting
Phase 4
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04347473
Recruiting
Phase 4
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Psoriasis
Psoriasis Treatment Center of Central New Jersey30 enrolled1 locationNCT03827876
Recruiting
Not Applicable
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Psoriasis
Psoriasis Treatment Center of Central New Jersey30 enrolled1 locationNCT03392337